http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RS-51082-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_767d0d7a00b5d921c9324ee92aa9f0ca
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-167
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-167
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
filingDate 2003-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_84ad89246da0f73c874eaa866fe48663
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dde4aff5d6182bbea1231b3efdc247cf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a704eec2f10bf699b8b6a4136b7b604d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5eae0f82f91d14402b7eec9ac919dec3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_21ac9619620a6e1be9c9850da0cbf472
publicationDate 2010-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RS-51082-B
titleOfInvention SYNERGISTIC COMBINATION INCLUDING ROFLUMILAS AND (R.R.) -FORMOTEROL
abstract A medicament comprising roflumilast, a pharmacologically acceptable salt of roflumilast or roflumilast N-oxide in combination with R, R-formoterol or a pharmacologically acceptable salt of R, R-formoterol. The application comprises a further 12 claims.
priorityDate 2002-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419571772
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9940999
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID449193
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422020808

Total number of triples: 25.